Stem Cell Therapies for Inflammatory Bowel Disease

Amy Lightner

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations


Purpose of Review: Stem cell therapies have demonstrated safety and efficacy in the treatment of perianal Crohn’s disease as compared to conventional therapy. Thus, an understanding of their place in the treatment algorithm for inflammatory bowel disease has become imperative as we move into an era of regenerative medicine. Recent Findings: There have now been over a dozen clinical trials highlighting stem cells as a useful therapeutic in Crohn’s disease. Due to the success in the local treatment for perianal Crohn’s disease, investigation is continuing in the space of targeted systemic delivery for the treatment of luminal disease. Summary: As we increase the number of patients treated in clinical trials, it is imperative to define the optimal cell donor, optimize treatment dosing and retreatment protocols, and understand methods for safely targeting and treating intraluminal disease.

Original languageEnglish (US)
Article number16
JournalCurrent gastroenterology reports
Issue number4
StatePublished - Apr 1 2019
Externally publishedYes


  • Luminal Crohn’s disease
  • Mesenchymal stem cells
  • Perianal Crohn’s disease
  • Regenerative medicine
  • Stem cells

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Stem Cell Therapies for Inflammatory Bowel Disease'. Together they form a unique fingerprint.

Cite this